Pregnant women and young children aged <18 years;
Patients with underlying disease cases without the possibility of resuscitation (e.g., terminal cancer);
Patients with do-not-resuscitate (DNR) status;
Death by excessive bleeding (e.g., abdominal main artery rupture);
Patients who have experienced in-hospital CA;
Patients previously treated with steroid, anti-cancer medicine, or immunosuppression treatment before CA;
Patients already been registered with other studies; or
Patients from whom informed consent cannot be obtained

NCT03317197_exc_T1
Person
women
NCT03317197_exc_T2
Person
young children
NCT03317197_exc_T3
Person
aged
NCT03317197_exc_T4
Value
<18 years
NCT03317197_exc_T5
Condition
terminal cancer
NCT03317197_exc_T6
Condition
underlying disease
NCT03317197_exc_T7
Qualifier
without the possibility of resuscitation
NCT03317197_exc_T8
Observation
do-not-resuscitate (DNR) status
NCT03317197_exc_T10
Condition
Death by excessive bleeding
NCT03317197_exc_T9
Condition
main artery rupture
NCT03317197_exc_T11
Qualifier
abdominal
NCT03317197_exc_T12
Scope
abdominal main artery rupture
NCT03317197_exc_T13
Condition
CA
NCT03317197_exc_T14
Visit
hospital
NCT03317197_exc_T15
Qualifier
in-hospital
NCT03317197_exc_T16
Drug
anti-cancer medicine
NCT03317197_exc_T17
Drug
steroid
NCT03317197_exc_T18
Procedure
immunosuppression treatment
NCT03317197_exc_T19
Temporal
before CA
NCT03317197_exc_T20
Condition
CA
NCT03317197_exc_T22
Temporal
previously
NCT03317197_exc_T23
Procedure
treated
NCT03317197_exc_T24
Scope
steroid, anti-cancer medicine